2Benninger MS, Gardner G, Grywalski C. Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia. Arch Otolaryngol Head Neck Surg, 2001, 127(9) : 1083-1085.
3Schweinfurth JM , Billante M, Courey MS. Risk factors and demographics in patients with spasmodic dysphonia. Laryngoscope, 2002,112(3) : 220-223.
8Tsunoda K, Amagai N, Kondou K, et al. Autologous replacement of the vocal fold: a new surgical approach for adduction-type spasmodic dysphonia. J Laryngol Otol, 2005, 119(3) : 222-225.
3Hartman DE, Abbs JH, Viswanat B.Clinical investigation of adductor spastic dysphonia[J]. Ann Otol Rhinol Laryngol,1988,97:247.
4广濑肇.音声障碍の临床[M].东京:ィンデルナ出版社,1998.103～117.
5Dedo HH, Behlau MS. Recurrent laryngeal nerve section for spastic dysphonia: 5～10year preliminary results in the first 300 cases[J]. Ann Otol Rhinol Laryngol,1991,100:274.
8Isshiki N, Tsuji DH, Yamamoto Y, et al. Midline lateralization thyroplasty for adductor spasmodic dysphania[J]. Ann Otol Rhinol Laryngol, 2000,109 : 187.
